Ten problematical issues identified by pathology review for multidisciplinary gynaecological oncology meetings
- Correspondence to Professor W Glenn McCluggage, Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast, BT12 6BA, Northern Ireland, UK; glenn.mccluggage{at}belfasttrust.hscni.net
- Accepted 16 August 2011
- Published Online First 19 October 2011
Abstract
Pathology review of gynaecological cancer specimens is often carried out as part of the working of gynaecological oncology multidisciplinary team meetings. This review describes the author's experience regarding the most common issues identified during this process. Ten subjects are covered; these range from histopathological interpretational errors to non-interpretational areas, for example, inappropriate use of the term ‘microinvasive cervical carcinoma’ and the use of inappropriate staging systems. This review is intended to be of practical use to the surgical pathologist reporting gynaecological cancer specimens.
- cervix
- colorectal cancer
- endometrium
- gall bladder
- gynaecological oncology
- histopathology
- multidisciplinary team meeting
- neoplasms
- oncogenes
- ovary
- pancreas
- pathology review
- p53
- uterus
Footnotes
-
Competing interests None.
-
Provenance and peer review Commissioned; externally peer reviewed.
